Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$510.08 +6.83 (+1.36%)
At close: Oct 9, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Sale and Maturity of Investments (2009 - 2026)

Updated

Analysis

Vertex Pharmaceuticals (VRTX) Sale and Maturity of Investments (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn -
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 159.00 Mn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn -
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn -
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn -
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn 1.02 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 2.04 Bn
10 Vertex Pharmaceuticals 129.23 Bn 101.23 Bn 2.84 Bn 2.35 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.35 Bn
Mar 31, 2026 2.21 Bn
Dec 31, 2025 1.09 Bn
Sep 30, 2025 1.33 Bn
Jun 30, 2025 1.84 Bn
Mar 31, 2025 1.64 Bn
Dec 31, 2024 1.46 Bn
Sep 30, 2024 1.11 Bn
Jun 30, 2024 1.18 Bn
Mar 31, 2024 710.50 Mn
Dec 31, 2023 218.10 Mn
Sep 30, 2023 331.20 Mn
Jun 30, 2023 239.80 Mn
Mar 31, 2023 50.00 Mn
Dec 31, 2022 484.10 Mn
Sep 30, 2022 193.60 Mn
Jun 30, 2022 112.60 Mn
Mar 31, 2022 129.70 Mn
Dec 31, 2021 47.20 Mn
Sep 30, 2021 230.80 Mn
API Access

Vertex Pharmaceuticals Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=VRTX&period=max&api_key=YOUR_API_KEY